Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
Clinical trial NCT02795676 · COMPLETED
Trial details
- NCT number
- NCT02795676
- Sponsor
- Protalix
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2021-10-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.